<!DOCTYPE html>
<html>

<head>
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <title>estradiol pharmacokinetics playground - estrannaise.js</title>

    <link rel="icon" type="image/png" sizes="96x96" href="img/favicon-96x96.png">
    <link rel="icon" type="image/png" sizes="48x48" href="img/favicon-48x48.png">
    <link rel="icon" type="image/png" sizes="32x32" href="img/favicon-32x32.png">

    <link rel="stylesheet" type="text/css" href="css/colors.css">
    <link rel="stylesheet" type="text/css" href="css/slider.css">
    <link rel="stylesheet" type="text/css" href="css/styles.css">

	<script type="importmap">
		{
			"imports": {
				"cubic-spline": "./lib/cubic-spline.js",
				"papaparse": "./lib/papaparse.js",
				"@observablehq/plot": "./lib/plot.js"
			}
		}
	</script>
	<link rel="modulepreload" href="lib/plot.js">
	<link rel="modulepreload" href="lib/papaparse.js">
	<link rel="modulepreload" href="lib/cubic-spline.js">
    <script type="module" src="src/estrannaise.js"></script>
</head>

<body>
<div id="dragndrop-zone">
    <div class="container">

        <div class="header">

            <div id="logo">
                <a href="img/estrannaise.png" style="background-color: var(--background-color);"><img src="img/favicon-96x96-bw.png" alt="estrannaise.js logo"></a>
            </div>

            <div id="title">
                <span id="titleh1">estrannaise<br>estradiol <a href="docs/ingredients/">pharmacokinetics</a> playground</span>
            </div>

            <div id="the-big-light" title="Switch between and remember night/day theme. Double-click to return to OS default.">
                <div class="slider-box">
                    <label class="switch">
                        <input type="checkbox" id="nightday-state">
                        <span class="slider round"></span>
                    </label>
                </div>
            </div>

            <div id="banner-container">
                <div id="banner">
                    <p><span>2024-12-20: New intramuscular EUn model</span></p>
                    <p>
                    <span>2024-12-09: v0.4.0 is out!</span>
                    <ul>
                        <li>Improved models for intramuscular EV/EEn/EC/EB</li>
                        <li>State persistence across sessions (click reset to clear)</li>
                        <li>Fudge factor because everyone's different (bottom left of figure)</li>
                    </ul>
                </p>
                    <strong>click banner to dismiss</strong>
                </div>
            </div>

        </div>

        <div id="ui-container">

            <div id="plot-region" class="centered-reflow"></div>

            <div id="options-container" class="centered-reflow">
                <input id="fudge-factor" class="flat-input" value="1.0" title="Fudge factor">
                <select id="dropdown-units" title="Change units for the estradiol concentration"></select>
                <select id="dropdown-presets" title="Load a preset">
                    <option value="" selected disabled>select a preset</option>
                </select>
                <button id="menstrual-cycle-button" class="flat-button" title="Turn on/off the display of the menstrual cycle data">
                    menstrual cycle
                </button>
                <button id="target-range-button" class="flat-button" title="Turn on/off the display of target mean estradiol range">
                    target range
                </button>
                <button id="reset-button" class="flat-button" title="Click to clear all, double-click to reset to default.">
                    clear/reset
                </button>
                <button id="share-button" class="flat-button" title="Share the current state of the simulator as an arcane URL">
                    share url
                </button>
            </div>

            <div id="steadystate-container">

                <div id="steadystate-title" class="centered-reflow">
                    repeated doses
                </div>

                <div id="steadystate-buttons" class="centered-reflow">
                    <div>
                        <button id="clear-steadystates-button" class="flat-button" title="Clear all steady-state entries">clear</button>
                    </div>
                </div>

                <div id="steadystate-table-container" class="centered-reflow">
                    <table id="steadystate-table" class="centered-reflow">
                        <thead>
                            <tr>
                                <th title="Buttons in this column allow you to turn the visibility of the curve on/off">c</th>
                                <th title="Buttons in this column allow you to turn the visibility of the uncertainty cloud on/off">u</th>
                                <th>dose</th>
                                <th>every</th>
                                <th>model</th>
                                <th></th>
                            </tr>
                        </thead>
                        <tbody>
                        </tbody>
                    </table>
                </div>
            </div>

            <div id="customdose-container">

                <div id="customdose-title" class="centered-reflow">
                    custom doses
                </div>
                <div id="customdose-buttons" class="centered-reflow">
                    <div>
                        <button id="guess-button" class="flat-button" title="Duplicate last entry when in 'days as interval mode'. Guess and autofill next dose given the last two or three entries when in 'absolute days' mode">autofill</button>
                        <button id="clear-doses-button" class="flat-button" title="Clear all entries of the custom dose curve">clear</button>
                        <input type="file" id="csv-file" accept=".csv">
                        <button id="import-csv-dialog" class="flat-button">import</button>
                        <button id="export-csv-button" class="flat-button">export</button>
                    </div>
                </div>

                <div id="customdose-table-container" class="centered-reflow">
                    <table id="customdose-table" class="centered-reflow">
                        <thead>
                            <tr>
                                <th title="Turn visibility of curve on/off">c</th>
                                <th title="Turn visibility of uncertainty cloud on/off">u</th>
                                <th>dose</th>
                                <th><select id="dropdown-daysinput" title="Change the way days are interpreted as inputs in the custom curve">
                                        <option value="intervals">interval</option>
                                        <option value="absolute">absolute</option>
                                        <option value="convert">convert abs&harr;int</option>
                                    </select>
                                </th>
                                <th>model</th>
                                <th></th>
                            </tr>
                        </thead>
                        <tbody>
                        </tbody>
                    </table>
                </div>
                <span id="dragndrop-text" class="small-text">drag-n-drop csv anywhere to import</span>
            </div>
        </div>

        <div id="bottom-text">

            <p>
                <span class="standout-text">The line is a lie!</span> The cloud a little less so.
                All current models tend to underestimate uncertainty, particularly patch models,
                which may underestimate it by up to a factor of 10.
            </p>

            <p class="indent">The cloud visualization does not represent individual data points; rather, it
                illustrates the uncertainty inherent in the model itself. Importantly, this visualization
                underestimates the total uncertainty, as it only captures the uncertainty associated with
                the population mean, or more accurately the uncertainty in the parameters of the deterministic
                estradiol curve. It does not account for the full distribution of outcomes across the broader
                population. This limitation is expected to be addressed in future updates by incorporating
                a more comprehensive representation of uncertainty, including population variability
                around the deterministic curve.
            </p>

            <p class="indent">Current understanding suggests that the pharmacokinetics of estradiol ester
                depots is highly variable and influenced by numerous factors that are not well understood
                or consistently accounted for in existing models of this class of drugs. These factors can
                lead to significantly divergent outcomes and are often poorly represented, if at all, in
                current modeling efforts. Key variables include ester concentration, the type of oil used,
                the proportion and type of excipients (e.g., benzyl benzoate and benzyl alcohol), injection
                site, injection depth, route of administration (intramuscular vs. subcutaneous), individual
                metabolic differences, lifestyles and health, and interactions with concomitant medications.
                While some of these factors may be partially captured in the model's uncertainty when data is
                abundant and derived from multiple studies under varying conditions, this is rarely the case.
                Many of these factors also apply to other routes of estradiol administration, such as transdermal,
                oral, and sublingual. Efforts are underway to improve and generalize the models to better reflect
                this variability, though their accuracy and scope will always be constrained by the availability
                and quality of the underlying data.
            </p>

            <p class="indent">All pharmacokinetic data used to infer intramuscular models have been manually
                redigitized from scratch from the original studies cited in the <a href="https://transfemscience.org/articles/injectable-e2-meta-analysis/" target="_blank">tfs meta-analysis</a>.
                Where possible, per-patient data were further segmented into individual datasets rather than
                represented by their global average. Please consult the <a href="docs/refs/">full list of references</a>
                for a comprehensive account of all data sources.
            </p>

            <p class="indent">Additionally, we employ a distinct, process-centric strategy for handling baseline
                data. While the TFS simulator applies a global offset to force the first data point to zero
                during preprocessing, our approach leaves the data unaltered and incorporates a decaying
                contribution to capture baseline dynamics. This contribution is represented by a simple structure
                that transitions from a constant level before administration to a decaying exponential afterward,
                which is then combined with the full three-compartment pharmacokinetic model. Together, these
                components form the overall estradiol curve, describing the exogenous administration of estradiol
                esters while seamlessly accounting for uncertainty in the baseline data. This approach provides
                a more accurate representation of the elimination process and eventual suppression of endogenous
                estradiol production, while naturally resolving the issue of negative levels that can arise with
                global offset corrections.
            </p>

            <p class="indent">
                Note that pharmacokinetic data for estradiol enanthate (<span class="standout-text">een im</span>)
                and intramuscular estradiol undecylate (<span class="standout-text">eun im</span>) are substantially
                sparser compared to other esters. The data for estradiol enanthate comes entirely from studies
                on Perlutal from the 80s and 90s. The data for estradiol undecylate comes from only two studies
                (Vermeulen 1975 and Geppert's 1975 thesis) which both stopped measuring estradiol levels at
                the 2 week mark, thus preventing the model from capturing the full pharmacokinetic profile of the
                elimination phase and with it an accurate estimate of the terminal half-life.
            </p>

            <p class="indent">The model for subcutaneous estradiol undecylate depots using castor oil
                (<span class="standout-text">eun casubq</span>) was inferred by augmenting the
                <span class="standout-text">eun im</span> and <span class="standout-text">een im</span>
                models with sparse self-reported community data (n=4). As a result, its predictions are
                associated with high uncertainty.
            </p>

            <p class="indent">The once-weekly (<span class="standout-text">patch ow</span>) and
                twice-weekly (<span class="standout-text">patch tw</span>) patch models were derived from
                two studies by Houssain et al. and drug labels for Climara, Mylan, and Menostar matrix patches.
                See the list of references above. Based on insights from self-reported community data, it
                is important to note that both models significantly underestimate uncertainty, which is
                likely closer to ten times greater than currently represented. Future updates will aim to
                address this discrepancy. Additionally, the interface currently does not allow for adjustments
                to the patch wearing period (they are fixed at 3&frac12; and 7 days) though this
                functionality is planned in future updates.
            </p>

            <p class="indent">Menstrual cycle data were sourced from
                <a href="https://doi.org/10.1515/CCLM.2006.160" target="_blank">Stricker et al. 2006</a>.
                Estradiol (E2), progesterone (P), luteinizing hormone (LH), and follicle-stimulating hormone (FSH)
                data <a href="data/menstrualcycle_stricker2006.csv">are available for download</a>.
            </p>

            <p class="indent">Target ranges for hormone levels are based on guidance from
                the <a href="https://doi.org/10.1080/26895269.2022.2100644" target="_blank">WPATH Standards of Care, Version 8</a>
                and the <a href="https://doi.org/10.1210/jc.2017-01658" target="_blank">Endocrine Societyâ€™s Clinical Practice Guideline</a>.
            </p>

            <br>

            <p><strong>Note on "inappropriate WPATH regimens" presets</strong>
                <p class="indent">The WPATH Standards of Care (Appendix C, page S254) lists several hormone
                    replacement therapy (HRT) regimens for transfeminine individuals. However, some of these
                    recommendations may not align with WPATH's own guidelines and could even pose potential
                    risks. Here's a breakdown of the issues.</p>
                <ol>
                    <li><strong>Issue with 5-30 mg intramuscular injections every 2 weeks:</strong></li>
                    <ul>
                        <li>The half-life of estradiol valerate (EV) and estradiol cypionate (EC) are approximately
                            4 and 8 days, respectively. Administering injections every two weeks necessitates higher doses,
                            leading to significant fluctuations in hormone levels. This can result in very high levels
                            shortly after the injection and very low levels before the next dose, potentially causing
                            mood swings in susceptible individuals and risking the reactivation of testosterone production in
                            the last few days leading up to the next injection.
                        </li>
                        <li>At the lower dose limit (5 mg every 2 weeks), estradiol levels may fall below the threshold
                            for monotherapy after approximately 7 days, risking the restart of testosterone production and
                            estradiol levels dropping below 100 pg/mL, which contradicts WPATH's recommended levels.
                        </li>
                        <li>At the upper dose limit (30 mg every 2 weeks), estradiol levels may spike dangerously high
                            (upwards of 2,000 pg/mL with EV and 1,000 pg/mL with EC), increasing the risk of thrombotic
                            events in predisposed individuals.
                        </li>
                    </ul>
                    <li><strong>Issue with 2-10 mg intramuscular injections every week:</strong></li>
                    <ul>
                        <li>At the lower dose limit (2 mg weekly), estradiol levels may remain consistently around
                            100 pg/mL throughout the week with EC and below 100 pg/mL during the second half of the
                            week with EV, potentially necessitating the use of an anti-androgen to suppress testosterone
                            production or block its effects.
                        </li>
                        <li>Using the upper dose limit (10 mg every week), estradiol levels may consistently exceed
                            300-400 pg/mL, significantly higher than WPATH's recommended levels.
                        </li>
                    </ul>
                </ol>
                For a more detailed analysis, readers are referred to <a href="https://doi.org/10.1016/j.eprac.2024.05.008" target="_blank">Rothman et al. 2024</a>.
                Note that while these contradictions and issues have been widely recognized and discussed
                within the trans community for some time, the recent inclusion of these concerns in the medical
                literature represents an important development in aligning clinical guidelines with community
                experience and evidence.
            </p>

            <br>
            <p>
                <h4 class="standout-text">Acknowledgements</h4>
                Initial idea and development by alix. Code improvement and refactoring by Meringue.
                Help with data digitization from Annie.
                Additional help from Diamond, GearKite, Jess, Xea, and idk2848.

                <br/><br/>Encouragements, entertainment, feedback, and memetic pumping from
                <br/>Torble Lea photino emily Izzy Ashley Sapphira
            </p>
            <br>
            <p>
                <h4 class="standout-text">DISCLAIMER</h4>
                This page, designed as a playground to explore estradiol pharmacokinetics, provides a simulation
                for informational and entertainment purposes only. The developer(s) cannot guarantee the accuracy of
                the predictions generated by the simulator. Users acknowledge that the software is offered "as is,"
                without any warranties. The developer(s) assume no liability for direct or indirect damages,
                either physical, psychological, or otherwise, resulting from the use of the simulator.
                Users are strongly advised to exercise caution and seek professional medical advice for
                health-related queries.
            </p>
            <br>
            <p class="standout-text">
                estrannaise.js is entirely client-side. Your data, whether entered, imported, stashed,
                or loaded from a shared url, remains exclusively within your browser and will never be
                transmitted to the developer(s) or any third-party by our application.
            </p>
            <br>
            <p>
                mit license (c) 2025 alix<br>
                <a href="javascript_licenses.html" data-jslicense="1">JavaScript license information</a><br>
                <a href="https://github.com/WHSAH/estrannaise.js" target="_blank">estrannaise.js (v0.4.0)</a>
            </p>
            <br>
            <p>
                If this kind of thing interests you, you can contact me on signal a1ix2.91 or by email _a1ix2_at_proton_dot_me_ (no underscores).
                For feedback, bugs, and feature requests submit an issue on github.
            </p>
            <br>

        </div>

        <div id="tipjars">
            <p>
                <span id="tipjars-header">funding agency simulator</span><br>
                <span id="xmr-tipjar-text">xmr</span><span id="copy-xmr" class="copy-crypto">85Tz3LXEU65h6Lf6tjXLk744FMYW5f4yeTx1pVjsqURQ3YQxtawQJoMAcXDAtEbyFhBLZeEdsXGmpTy5RzzDCWQo6QvcvzE</span><br>
                <span id="btc-tipjar-text">btc</span><span id="copy-btc" class="copy-crypto">1EK9wp876WhA8W3m7a1mR1Aka6LDsoWpCR</span><br>
                <span id="ltc-tipjar-text">ltc</span><span id="copy-ltc" class="copy-crypto">ltc1qz4auzjh0dtfqlu5yjk85tvz83aed60ajmy8src</span><br>
                <span id="eth-tipjar-text">eth</span><span id="copy-eth" class="copy-crypto">0xccC52F9E0CFA1D365A69b5D624dA357192bb3c83</span>
            </p>
        </div>

    </div>
</div>
</body>

</html>
